Previous Article | Next Article ![]()
Infect. Immun., Sep 1997, 3631-3637, Vol 65, No. 9
JR Daugherty, CI Murphy, LA Doros-Richert, A Barbosa, LO Kashala, WR Ballou, NJ Snellings, CF Ockenhouse and DE Lanar
The erythrocyte binding antigen EBA-175 is a 175-kDa Plasmodium falciparum
protein which mediates merozoite invasion of erythrocytes in a sialic
acid-dependent manner. The purpose of this study was to produce recombinant
EBA-175 polypeptide domains which have previously been identified as being
involved in the interaction of EBA-175 with erythrocytes and to determine
whether these polypeptides are recognized by malaria-specific antibodies.
The eba-175 gene was cloned by PCR from genomic DNA isolated from the 3D7
strain of P. falciparum. The predicted protein sequence was highly
conserved with that predicted from the published eba-175 gene sequences
from the Camp and FCR-3 strains of P. falciparum and contained the F
segment divergent region. Purified recombinant EBA-175 polypeptide
fragments, expressed as glutathione S-transferase fusion proteins in insect
cells by using the baculovirus system, were recognized by antibodies
present in serum from a drug-cured, malaria-immune Aotus nancymai monkey.
The fusion proteins were also recognized by antibodies present in sera from
individuals residing in areas where malaria is endemic. In both cases the
antibodies specifically recognized the EBA-175 polypeptide portion of the
fusion proteins. Antibodies raised in rabbits immunized with the
recombinant fusion proteins recognized parasite proteins present in
schizont-infected erythrocytes. Our results suggest that these regions of
the EBA-175 protein are targets for the immune response against malaria and
support their further study as possible vaccine components.
Copyright © 1997, American Society for Microbiology
Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies
Department of Immunology, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|